
Immuron Limited IMRN
$ 0.83
0.0%
Annual report 2022
added 09-09-2022
Immuron Limited ROA Ratio 2011-2026 | IMRN
Annual ROA Ratio Immuron Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.48 | -30.99 | -47.2 | -54.11 | -32.58 | -82.11 | - | - | - | - | - | - |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -11.48 | -82.11 | -43.08 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.85 | 3.22 % | $ 9.26 B | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
6.32 | $ 330.55 | -0.85 % | $ 43.3 B | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-35.68 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
23.87 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-27.33 | $ 7.51 | 1.21 % | $ 74.2 M | ||
|
Allakos
ALLK
|
-76.23 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-218.41 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1008.51 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.02 | $ 21.68 | - | $ 1.01 B | ||
|
CymaBay Therapeutics
CBAY
|
-24.24 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
65.02 | $ 99.49 | 0.02 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Burford Capital Limited
BUR
|
5.51 | $ 4.79 | 1.06 % | $ 771 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Cabaletta Bio
CABA
|
-101.68 | $ 3.46 | 1.62 % | $ 348 M | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-103.3 | $ 3.17 | -2.16 % | $ 5.22 M | ||
|
AgeX Therapeutics
AGE
|
-275.96 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-315.07 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-19.95 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-1.42 | $ 1.5 | -3.23 % | $ 386 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-52.23 | $ 4.24 | -0.12 % | $ 453 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 24.54 | -0.18 % | $ 3.12 B | ||
|
AIkido Pharma
AIKI
|
-19.87 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
26.14 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.48 | -1.01 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
3.5 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-57.1 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-95.49 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
-44.38 | $ 33.97 | 0.3 % | $ 2.26 B | ||
|
bluebird bio
BLUE
|
-34.23 | - | - | $ 546 M | ||
|
CNS Pharmaceuticals
CNSP
|
-183.81 | $ 2.67 | -2.91 % | $ 1.18 M | ||
|
AstraZeneca PLC
AZN
|
0.11 | - | - | $ 96.9 B |